Researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without problematic side effects.

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or metastatic hormone receptor HR+, HER2- breast cancer in adult patients who have previously received endocrine-based therapy and chemotherapy for unresectable or metastatic disease, according to a news release.

The Breast Cancer Risk Assessment Tool (BCRAT), also known as The Gail Model, is a tool used by healthcare professionals to estimate a woman's risk of developing invasive breast cancer within the next five years and within her lifetime (up to age 90), according to the National Cancer Institute.

Breast Cancer Now said the treatment, which is also known as Lynparza, will be an “valuable alternative” for patients. The National Institute for Health and Care Excellence (Nice) said the drug can be used for “treating HER2-negative locally advanced ...

With medical advances, more than 169,000 people in the United States are living with metastatic breast cancer.

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by the American Cancer Society.

Flossmoor resident and cancer survivor Ann Jackson launched the Center for Food Equity in Medicine at Flossmoor Community Church.

An expert spoke with CURE about providers’ “two-fold goal” when using chemotherapy to treat patients with breast cancer.

The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with breast cancer, according to data presented at San Antonio Breast Cancer Symposium.

Scientists have developed a new AI-based method to diagnose breast cancer at very early stages. The approach could save lives but there are hurdles to it being used in hospitals.

After getting a metastatic breast cancer diagnosis, you may experience anxiety and depression. Here are some ways to manage and when to speak with a healthcare provider.